Hepatitis E Virus Open Reading Frame protein
recombinant, E. coli
| Cat. No. | Amount | Price (EUR) | Buy / Note |
|---|---|---|---|
| PR-1187 | 100 μg | 300,70 | Add to Basket/Quote Add to Notepad |
For general laboratory use.
Shipping: shipped on gel packs
Storage Conditions: store at -20 °C
avoid freeze/thaw cycles
Shelf Life: 12 months
Purity: > 95 % (SDS-PAGE)
Form: liquid (Supplied in 20 mM Tris-HCl pH 8.0, 10 mM beta-mercaptoethanol and 8 M urea)
Applications:
Antigen in ELISA and Western blots, excellent antigen for detection of HEV with minimal specificity problems.
Description:
The E. coli derived HEV protein is fused with beta-galactosidase at the N-Terminus. The protein contains immunodominant HEV ORF3 fragment, amino acids: 92-123. It is purified by proprietary chromatographic techniques.
Background: Hepatitis E virus (HEV) is a major human pathogen in much of the developing world. It is a plus-strand RNA virus with a 7.2kb polyadenylated genome consisting of three open reading frames, ORF1, ORF2, and ORF3. Of these, ORF2 encodes the major capsid protein of the virus and ORF3 encodes a small protein of unknown function.
Specificity: Immunoreactive with sera of HEV-infected individuals.
BIOZ Product Citations:
Selected References:
Surjit et al. (2004) The ORF2 protein of hepatitis E virus binds the 5' region of viral RNA. J. Virol. 78:320.
Tyagi et al. (2001) The full-length and N-terminal deletion of ORF2 protein of hepatitis E virus can dimerize. Biochem. Biophys. Res. Commun. 286:214.
Tuteja et al. (2000) Augmentation of immune responses to hepatitis E virus ORF2 DNA vaccination by codelivery of cytokine genes. Viral. Immunol. 13:169.
Li et al. (2000) Recombinant subunit ORF2.1 antigen and induction of antibody against immunodominant epitopes in the hepatitis E virus capsid protein. J. Med. Virol. 60:379.
Powered by Bioz
